Veeva Systems (VEEV) Earnings Date & Reports

Key Takeaways

• Veeva Systems reports fiscal 2027 second-quarter results after market close on August 26, 2026, for the period ended July 31, 2026.
• Management guided to revenue of $902 million to $905 million and non-GAAP earnings per share (EPS) of $2.21 to $2.22.
• Wall Street consensus sits near the top of that range, at roughly $905 million in revenue and about $2.22 in EPS.
• The year-ago quarter delivered $789.1 million in revenue and $1.99 in non-GAAP EPS, implying roughly 14% to 15% top-line growth at the midpoint.
• Investors will watch Vault CRM migration progress, Veeva AI adoption, and subscription revenue momentum.

Earnings Context and Why It Matters

Veeva Systems is a leading provider of cloud-based software for the life sciences industry, serving pharmaceutical, biotechnology, and medical device companies. Its results offer a useful read on enterprise software spending across healthcare, a relatively resilient demand environment. The company has consistently exceeded estimates, most recently reporting fiscal 2027 first-quarter revenue of $882.9 million, up 16.3% year over year, alongside non-GAAP EPS of $2.24. With Veeva investing heavily in artificial intelligence (AI) and CRM migration while absorbing service-related margin pressure, this report is an important test of whether growth can hold up as spending priorities shift.

Earnings Expectations

For the second quarter of fiscal 2027 (the three months ended July 31, 2026), Veeva guided revenue to between $902.0 million and $905.0 million and non-GAAP EPS (a profitability measure that excludes certain one-time and non-cash items) to between $2.21 and $2.22. Analyst consensus sits near the top of that guidance range, at approximately $905 million in revenue and $2.22 in EPS.

That would represent roughly 14% to 15% revenue growth compared with the $789.1 million reported in the same quarter a year earlier, when non-GAAP EPS came in at $1.99. For full fiscal 2027, management raised its outlook to revenue of $3.635 billion to $3.645 billion and non-GAAP EPS of approximately $9.05, signaling confidence in second-half momentum.

Beyond the headline figures, investors will scrutinize subscription revenue (which reached $730.2 million in the prior quarter, up 15% year over year), billings, and operating margin. Historically, Veeva shares have reacted modestly even to strong results, suggesting the market already prices in a high level of execution.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors monitoring names like VEEV around earnings, the AI Screener offers a structured way to surface relevant candidates and compare signals across the healthcare software sector.

Market Reaction and Investor Sentiment

Heading into the report, sentiment is cautiously optimistic but tempered by a high expectations bar. Despite beating estimates in the fiscal first quarter, Veeva shares traded lower in the immediate aftermath, reflecting investor concerns about margin pressure from services investments and the cost of scaling its R&D solutions. For this quarter, the market will be watching whether subscription growth remains durable and whether AI-related initiatives begin to translate into measurable revenue. Key risk factors include billings growth that has lagged revenue growth, ongoing pressure on professional services margins, and any signs of slowing demand from life sciences customers facing budget constraints.

Forward Outlook and Key Factors to Monitor

Following the report, investors should focus on how Veeva frames its full-year trajectory. Management already raised its fiscal 2027 guidance in June, so the key question is whether second-half targets remain intact or shift again. Any update on the balance between subscription and services revenue will matter, since subscription is higher-margin and more predictive of future growth.

On the product front, Vault CRM migration remains a central story. With more than 150 customers live on Vault CRM and a win rate above 80% for migrations, continued conversion progress is a meaningful forward indicator. Investors will also listen for commentary on Veeva's Falcon AI platform and broader Vault AI adoption, as management has positioned these tools as the foundation of its next growth phase.

Additionally, watch the Crossix measurement business and the integration of the Ostro acquisition, both of which management has highlighted as durable growth engines. Billings, free cash flow, and operating margin will help clarify whether near-term investment pressure is easing. While the long-term narrative around AI and industry-specific cloud remains intact, near-term execution across these metrics will likely set the tone for the stock.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations